ClinicalTrialsFinder

Bronchiolitis Obliterans (BO) Clinical Trials in Basel

1 recruitingBasel, Switzerland

Showing 1–1 of 1 trials

Recruiting
Phase 2

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
University Hospital, Basel, Switzerland20 enrolled3 locationsNCT03805477